During the past decade, Nordwest-Krankenhaus Sanderbusch conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nordwest-Krankenhaus Sanderbusch" #1 collaborator was "Aesculap AG" with 1 trials as a collaborator and "Winicker Norimed GmbH" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Nordwest-Krankenhaus Sanderbusch" are "Acute Myeloid Leukemia (AML)" (1 trials), "Brain Ischemia With Non-valvular Atrial Fibrillation" (1 trials), "Cartilage Disease" (1 trials), "Higher Risk Myelodysplastic Syndromes (MDS With Excess Blasts 2)" (1 trials) and "Secondary Prevention" (1 trials). Many other conditions were trialed in "Nordwest-Krankenhaus Sanderbusch" in a lesser frequency.

Most popular intervention types in "Nordwest-Krankenhaus Sanderbusch" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "ASA 100 mg" (1 trials), "dabigatran etexilate" (1 trials), "optional ASA as comedication" (1 trials), "placebo to ASA" (1 trials) and "placebo to dabigatran etexilate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nordwest-Krankenhaus Sanderbusch" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Nordwest-Krankenhaus Sanderbusch". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Nordwest-Krankenhaus Sanderbusch, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nordwest-Krankenhaus Sanderbusch, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".